Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2012
05/16/2012CN102459184A 取代的烯胺羰基化合物 Substituted enamine carbonyl compound
05/16/2012CN102459183A Inhibitors of human immunodeficiency virus replication
05/16/2012CN102459175A 用于治疗糖尿病的哌啶衍生物 For treating diabetes piperidine derivative
05/16/2012CN102459172A 四环化合物 Tetracyclic compounds
05/16/2012CN102459169A 氧化还原药物衍生物 Redox drug derivatives
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459166A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102458659A 不对称氢化催化剂 Asymmetric hydrogenation catalyst
05/16/2012CN102458394A Treatment or prophylaxis of proliferative conditions
05/16/2012CN102453025A Lapatinib intermediate crystal form and preparation method thereof
05/16/2012CN102452974A Organic light-emitting device
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178671 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
05/15/2012US8178668 2-aminopyridine kinase inhibitors
05/15/2012US8178579 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
05/15/2012US8178559 Organic compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178545 Dual small molecule inhibitors of cancer and angiogenesis
05/15/2012US8178531 Antiviral agents
05/15/2012CA2643005C Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof
05/15/2012CA2517361C Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/10/2012WO2012061602A1 Isoindolinone kinase inhibitors
05/10/2012WO2012061428A2 Nicotinamides as jak kinase modulators
05/10/2012WO2012061415A1 Oxypyrimidines as syk modulators
05/10/2012WO2012061012A2 4-amino-2h-pyran-2-one analogs as anticancer agents
05/10/2012WO2012060397A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
05/10/2012WO2012059497A1 N-hetarylmethyl pyrazolylcarboxamides
05/10/2012WO2012019430A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2012017021A3 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/10/2012WO2011146589A3 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
05/10/2012US20120116094 Compositions comprising and methods for forming functionalized carbon-based nanostructures
05/10/2012US20120116083 Heteroaromatic pyrazinoylguanidine sodium channel blockers
05/10/2012US20120115907 Novel compounds as inhibitors of renin
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115876 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
05/10/2012US20120115870 Control of intraocular pressure using alk5 modulation agents
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115868 Novel triazole compounds ii
05/10/2012US20120115859 3,4,5-substituted piperidines as renin inhibitors
05/10/2012US20120115855 Inhibitors of hcv ns5a
05/10/2012US20120115851 Compound inhibiting in vivo phosphorus transport and medicine containing the same
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115724 Method of controlling undesired vegetation
05/10/2012US20120114600 Novel inhibitors of hepatitis c virus
05/10/2012US20120114535 Compound for inhibiting activity of ribonuclease, and container for storing nucleic acid containing the same
05/10/2012US20120112179 Fluoranthene compound and organic electroluminescence device using same
05/10/2012US20120112174 Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode
05/10/2012CA2819997A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
05/10/2012CA2816219A1 Benzamides and nicotinamides as syk modulators
05/10/2012CA2815117A1 N-hetarylmethyl pyrazolylcarboxamides
05/09/2012EP2450975A2 Compound for organic optoelectronic device and organic light emitting diode including the same
05/09/2012EP2450356A1 Carbazole and anthracene moiety containing light-emitting device material and light-emitting devices
05/09/2012EP2448934A1 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
05/09/2012EP2448930A1 Covalent inhibition of bacterial quorum sensing
05/09/2012EP2448928A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/09/2012EP2448574A1 Synthesis and use of fluorophore-tagged antimalarials
05/09/2012EP2274297B1 Pyrrolidinone glucokinase activators
05/09/2012EP1501467B1 Heterocyclo inhibitors of potassium channel function
05/09/2012EP1492536B1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/09/2012EP1423107B1 Fatty alcohol drug conjugates
05/09/2012CN1809539B Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2
05/09/2012CN1626527B Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative
05/09/2012CN102448957A Compounds as cannabinoid receptor ligands
05/09/2012CN102448956A Hepatitis c virus inhibitors
05/09/2012CN102448951A Therapeutic compositions and related methods of use
05/09/2012CN102448943A 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
05/09/2012CN102448940A Pharmaceutical composition for treating or preventing glaucoma
05/09/2012CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers
05/09/2012CN102448936A Heterocyclic antiviral compounds
05/09/2012CN102448920A Antiviral compounds and uses thereof
05/09/2012CN102448548A Heterocyclic antiviral compounds
05/09/2012CN102442997A Quinoline derivative as well as preparation method thereof, midbody and application thereof
05/09/2012CN102442973A Method for closed-loop synthesis of benzoglioxaline and benzothiazole compounds by catalytic oxidation of primary alcohol
05/09/2012CN101633644B N3 alkylated benzimidazole derivatives as mek inhibitors
05/09/2012CN101560191B Alpha-menaphthyl substituted spiro bis(oxazoline) ligands, synthetic method and application thereof in synthesizing pyrazolidine derivatives
05/09/2012CN101511796B Imidazole derivative
05/09/2012CN101022807B Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
05/08/2012US8173682 Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
05/08/2012US8173651 Pyridine compounds
05/08/2012US8173646 FAB I inhibitors
05/08/2012CA2561628C Histamine h3 receptor agents, preparation and therapeutic uses
05/08/2012CA2513660C Hydroxyl compounds and compositions for cholesterol management and related uses
05/03/2012WO2012058254A1 Benzimidazole inhibitors of leukotriene production
05/03/2012WO2012057312A1 Tau imaging probe
05/03/2012WO2012055994A1 Process for preparing olmesartan medoxomil
05/03/2012WO2012055380A1 A method of obtaining olmesartan medoxomil
05/03/2012WO2012018235A3 Method for preparing decitabine with improved yield and purity
05/03/2012WO2011115513A9 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
05/03/2012WO2011107608A8 Heterocyclic amides as rock inhibitors
05/03/2012US20120108815 Bifunctional/polyfunctional dopamine d2/d3 agonist as neuroprotective agents for treatment of neurodegenerative diseases
05/03/2012US20120108635 Insecticidal Arylpyrrolines
05/03/2012US20120108631 Sulfonamides for the Modulation of PKM2
05/03/2012US20120108605 O-glcnac transferase inhibitors and uses thereof
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108600 Substituted 4-hydroxypyrimidine-5-carboxamides
05/03/2012US20120108595 Platelet-activating factor receptor antagonists
05/03/2012US20120108565 Pyrrole carboxylic acid derivatives as antibacterial agents
05/03/2012US20120108545 Trioxane Monomers and Dimers
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 694